Topical ruxolitinib
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Topical ruxolitinib, covering 2024-12-05 to 2025-07-31. Get the full timeline:
Most recent: Clinical Trial Update: Topical Ruxolitinib Evaluation in Chronic Hand Eczema [Phase 2]